Jatin Shah - EVP, Karyopharm Therapeutics Inc

As of February 22, 2022


What is Jatin Shah's Net Worth?

The current estimated net worth of Karyopharm Therapeutics Inc's EVP, Jatin Shah, is estimated to be about $356.24K . Jatin Shah owns about 129,450 units of Karyopharm Therapeutics Inc common stock. In the last 3 years at Karyopharm Therapeutics Inc, Jatin Shah has sold an estimated value of $117.95K worth.

What is Jatin Shah's Past Insider Trading?

Jatin Shah's largest purchase order was 23,250 units , worth over $199.99K on May 11, 2021. Jatin Shah's largest sale order was 1,748 units , worth over $27.13K on February 17, 2021. In total, Jatin Shah has made about 13 transactions over 3 years of their time at Karyopharm Therapeutics Inc. Jatin Shah usually trades in February, with the busiest year in 2021. The most recent transaction was a sale order of 1,306 units , worth over $15.83K on February 22, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jatin Shah's' Mailing Address?

  • Mailing address is C/o Karyopharm Therapeutics, Inc. 85 Wells Avenue Newton MA 02459 MA

What are Karyopharm Therapeutics Inc's Past Insider Trades?

Karyopharm Therapeutics Inc's most recent insider trade came on June 14, 2022 by Sohanya Cheng who sold 1,551 units worth $8.07K . In the last 9 years, insiders at Karyopharm Therapeutics Inc have sold an estimated value of $147.74M and bought an estimated value of $33.43M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Sharon Shacham, Chief Scientific Officer,  Michael Kauffman, Director,  and Andreas Hadjimichael .

Karyopharm Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1